Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

FOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patients and Caregivers

for
Cancer Support, Oncology Patients, Caregivers
Location: Rochester NY, Detroit MI
Sponsor: Charles Kamen

Sex: All

Age: 18 - 70+

Code: NCT06800053

Recruiting

A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07619339

Phase 1, Recruiting

A Study of ZW251 in Participants With Advanced Solid Tumors

for
Hepatocellular Carcinoma,
Location: New York NY, Hackensack NJ, Louisville KY,
Sponsor: Zymeworks BC Inc.

Sex: All

Age: 18+

Code: NCT07164313

Phase 1, Recruiting

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

for
Advanced Malignancies, Advanced Cancer
Location: North Haven CT, New Haven CT, Deerfield Beach FL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07426757

Phase 1, Recruiting

Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New Brunswick NJ, Fairfax VA, San Antonio TX
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07128303

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use Cigarettes, E-cigarettes and Cannabis (Co-Tox Study)

for
Cigarette Smoking-Related Carcinoma, E-Cig Use
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18 - 25

Code: NCT07167225

Recruiting

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer (NSCLC),
Location: Fairfax VA, Atlanta GA, Ann Arbor MI, Peoria IL,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07140016

Phase 1, Recruiting

SLV-324 Treatment of Metastatic Solid Tumors

for
Metastatic Solid Tumors
Location: Philadelphia PA, Cleveland OH, St Louis MO, Houston TX,
Sponsor: Solve Therapeutics

Sex: All

Age: 18+

Code: NCT07108114

Phase 1, Recruiting

EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer

for
Cancer, Breast Cancer
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: Female

Age: 20 - 70+

Code: NCT07704476

Recruiting

IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced Solid Tumor
Location: East Brunswick NJ, Dallas TX, Los Angeles CA
Sponsor: Fortvita Biologics (USA)Inc.

Sex: All

Age: 18+

Code: NCT06349408

Phase 1, Recruiting

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: New York NY, Fairfax VA, Orlando FL, Nashville TN,
Sponsor: NEOK Bio, Inc.

Sex: All

Age: 18+

Code: NCT07612189

Phase 1, Recruiting

Prehabilitation Physical Therapy and Relaxation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery, ROAR-LCS Trial

for
Resectable Lung Non-Small Cell Carcinoma
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07584239

Recruiting

Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial

for
Brain Metastases, Adult,
Location: Burlington VT
Sponsor: University of Vermont Medical Center

Sex: All

Age: 18+

Code: NCT06974370

Phase 2, Recruiting

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

for
Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer,
Location: Boston MA, New Haven CT, Sarasota FL, Houston TX,
Sponsor: Immunome, Inc.

Sex: All

Age: 18+

Code: NCT07578571

Phase 1, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

for
Advanced Cancer, Advanced Solid Tumors
Location: Orlando FL, Nashville TN, New Orleans LA, Denver CO
Sponsor: Shanghai Allink Biotherapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06656390

Phase 1, Phase 2, Recruiting

A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Fairfax VA
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT07538804

Phase 1, Phase 2, Recruiting

Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors

for
Advanced Malignant Solid Neoplasm, Malignant Brain Neoplasm,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 39

Code: NCT07174661

Recruiting

SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care

for
Cancer, Financial Toxicity
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT07410689

Recruiting

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

for
Solid Tumor, Adult
Location: Washington D.C. DC, Florida City FL, Huntersville NC,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT06554795

Phase 1, Phase 2, Recruiting

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

for
HER2-Positive Solid Tumor
Location: Nashville TN
Sponsor: Yuhan Corporation

Sex: All

Age: 18+

Code: NCT05523947

Phase 1, Phase 2, Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial